InvestorsHub Logo
Followers 1
Posts 158
Boards Moderated 0
Alias Born 05/06/2019

Re: None

Friday, 05/22/2020 2:38:54 PM

Friday, May 22, 2020 2:38:54 PM

Post# of 3535
FYI - PAVmed Inc. (PAVM) CEO Lishan Aklog on Q1 2020 Results and Business Update

As I mentioned, Solys Diagnostics research and development plan for our noninvasive NDIR laser-based blood glucose monitoring technology is progressing very well. The working prototype has been completed and has been tested in a bench-top model. These fairly recent results show a very nice linear response curve across a wide range of glucose concentrations.

We expect to be -- to complete human and animal testing in the coming weeks. If that goes well and we achieve our target accuracy threshold we will be able to proceed on a commercial development plan.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KNW News